Literature DB >> 10476796

Characterization of alpha2 adrenergic receptor subtypes in human ocular tissue homogenates.

D B Bylund1, D M Chacko.   

Abstract

PURPOSE: To determine the predominant alpha2 adrenergic receptor subtypes present in the human eye.
METHODS: Saturation- and competition-receptor- binding experiments were performed with the radioligand [3H]RX821002 in human ciliary body, retinal pigmented epithelium-choriocapillaris, iris, and neurosensory retina. The affinities of various adrenergic antagonists in these ocular tissues were compared with their affinities for the cloned alpha2A, alpha2B, and alpha2C adrenergic receptor subtypes.
RESULTS: The density of alpha2 adrenergic receptors was highest in the iris (440 femtomoles/mg protein), lowest in the neurosensory retina (14 femtomoles/mg protein), and intermediate in the other two tissues (approximately 90 fmol/mg protein). The drug affinities in all four human ocular tissues were highly correlated (correlation coefficients between 0.94 and 0.97) with the affinities for the human alpha2A adrenergic receptor subtype and poorly correlated (correlation coefficients between 0.15 and 0.66) with the alpha2B and alpha2C subtypes.
CONCLUSIONS: In agreement with previous studies in several animal species, the alpha2 adrenergic receptors in the human ciliary body, retinal pigmented epithelium-choriocapillaris, iris, and neurosensory retina are predominately of the alpha2A subtype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476796

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

Review 1.  Potential neuroprotective biomolecules in ophthalmology.

Authors:  Mehrdad Afarid; Fatemeh Sanie-Jahromi
Journal:  Int Ophthalmol       Date:  2020-11-12       Impact factor: 2.031

Review 2.  Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection.

Authors:  F B Kalapesi; M T Coroneo; M A Hill
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

3.  Hyperglycemia Enhances Constriction of Retinal Venules via Activation of the Reverse-Mode Sodium-Calcium Exchanger.

Authors:  Yen-Lin Chen; Wenjuan Xu; Robert H Rosa; Lih Kuo; Travis W Hein
Journal:  Diabetes       Date:  2019-05-14       Impact factor: 9.461

4.  Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection.

Authors:  D W Evans; S L Hosking; D Gherghel; J D Bartlett
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

5.  Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension.

Authors:  Anna Galanopoulos; Ivan Goldberg
Journal:  Clin Ophthalmol       Date:  2009-06-02

6.  The effect of brimonidine on transepithelial resistance in a human retinal pigment epithelial cell line.

Authors:  Jung Hyun Park; Sung Joon Kim; Hyeong Gon Yu
Journal:  Korean J Ophthalmol       Date:  2010-06-05

7.  Safety threshold of intravitreal clonidine in rabbit's eyes.

Authors:  Homayoun Nikkhah; Kiumars Heidari Garfami; Mozhgan Rezaei Kanavi; Ebrahim Mohammad Nashtaei; Saeed Karimi; Masoud Soheilian
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

Review 8.  Neuroprotection in Glaucoma.

Authors:  Azadeh Doozandeh; Shahin Yazdani
Journal:  J Ophthalmic Vis Res       Date:  2016 Apr-Jun

9.  Experimental research in rats on the reactivity of new corneal blood vessels to adrenaline.

Authors:  Bianca Damian Daniela; Mihai Ghiță Aurelian; Istrate Sânziana; Cristina Coman Ioana
Journal:  Rom J Ophthalmol       Date:  2021 Jan-Mar

10.  Comparisons of α2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats.

Authors:  Anna R Connell; Michelle B Hookham; Dongxu Fu; Derek P Brazil; Timothy J Lyons; Jeremy Y Yu
Journal:  J Ocul Pharmacol Ther       Date:  2021-12-29       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.